Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Open Access
- 30 March 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 13 (4), e14002
- https://doi.org/10.15252/emmm.202114002
Abstract
Despite considerable efforts, therapeutic strategies targeting the Wnt pathway are still not clinically available. The pervasive role of Wnt‐βcatenin signaling for the control of stem cells during normal tissue homeostasis makes the on‐target toxicity of available therapeutic grade molecules an important limitation preventing their clinical introduction. The article in this issue of EMBO Molecular Medicine by Kaur et al (2021) reveals that treatment of Wnt‐addicted cancer cells with inhibitors of Wnt signaling induces a state of BRCAness leading to hypersensitivity to PARP inhibitors. This is a new example of induced synthetic lethality that could pave the way for new indications for PARP inhibitors or may contribute to the long‐awaited clinical introduction of therapeutic agents targeting the Wnt pathway.This publication has 11 references indexed in Scilit:
- WNT inhibition creates a BRCA‐like state in Wnt‐addicted cancerEMBO Molecular Medicine, 2021
- Synthetic lethality as an engine for cancer drug target discoveryNature Reviews Drug Discovery, 2019
- Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell NicheDevelopmental Cell, 2018
- BRCAness revisitedNature Reviews Cancer, 2016
- Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP InhibitorsAnnual Review of Medicine, 2015
- RNF43 is frequently mutated in colorectal and endometrial cancersNature Genetics, 2014
- The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strengthGenes & Development, 2014
- Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinomaProceedings of the National Academy of Sciences of the United States of America, 2013
- Recurrent R-spondin fusions in colon cancerNature, 2012
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumorsProceedings of the National Academy of Sciences of the United States of America, 2012